ID: ALA4287921

Max Phase: Preclinical

Molecular Formula: C27H29F3N4O7S

Molecular Weight: 461.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCC[n+]1nn(-c2ccc([N+](=O)[O-])cc2)c2c1C(=O)c1ccccc1C2=O.O=S(=O)([O-])C(F)(F)F

Standard InChI:  InChI=1S/C26H29N4O4.CHF3O3S/c1-2-3-4-5-6-7-8-11-18-28-23-24(26(32)22-13-10-9-12-21(22)25(23)31)29(27-28)19-14-16-20(17-15-19)30(33)34;2-1(3,4)8(5,6)7/h9-10,12-17H,2-8,11,18H2,1H3;(H,5,6,7)/q+1;/p-1

Standard InChI Key:  DQRIBSFLIOFJKF-UHFFFAOYSA-M

Associated Targets(Human)

BEAS-2B 690 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CCD-841CoN 99 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

COLO 205 50209 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 461.54Molecular Weight (Monoisotopic): 461.2183AlogP: 4.98#Rotatable Bonds: 11
Polar Surface Area: 98.98Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.89CX LogD: 3.89
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.14Np Likeness Score: -0.43

References

1. Subedi YP, Alfindee MN, Shrestha JP, Chang CT..  (2018)  Tuning the biological activity of cationic anthraquinone analogues specifically toward Staphylococcus aureus.,  157  [PMID:30130717] [10.1016/j.ejmech.2018.08.018]

Source